SearchUnderstanding medicinal cannabis access pathways
October 27, 2020
Australian registered medical practitioners who would like to access unapproved medicinal cannabis products for the treatment of appropriate patients outside of clinical trials may choose to do so through the Special Access Scheme (SAS) or the Authorised Prescriber Scheme. The SAS allows certain health practitioners to access therapeutic goods (such as medicines, medical devices or biologicals) that are not included in the Australian Register of Therapeutic Goods (ARTG) for a single patient.
Visit this video for Medicinal cannabis access for health professionals, providing an overview of access pathways for medicinal cannabis.
For further information regarding these processes, including a step-by-step resource for medical practitioners and information as to what to include in an application to the TGA please see 'Access to medicinal cannabis products: using access schemes' web page.
